
Ntrans Technologies At NTrans, we solve a key challenge in cell and gene therapy – efficient delivery and scalable manufacturing. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. We developed NTraCell, a transformative platform to bring the CRISPR editing complex into the cell through a simple formulation based on proprietary cell-penetrating peptides. Our delivery technology reduces process complexity and manufacturing costs. This GMP-ready technology achieves excellent scalability, gene editing efficiency and cell viability – redefining CGT manufacturing. Lead applications in allogeneic CAR-T therapies are advancing toward Phase I/II clinical studies, directly addressing critical scalability bottlenecks. Technology Developer

Ntrans Technologies

At NTrans, we solve a key challenge in cell and gene therapy – efficient delivery and scalable manufacturing. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. We developed NTraCell, a transformative platform to bring the CRISPR editing complex into the cell through a simple formulation based on proprietary cell-penetrating peptides. Our delivery technology reduces process complexity and manufacturing costs. This GMP-ready technology achieves excellent scalability, gene editing efficiency and cell viability – redefining CGT manufacturing. Lead applications in allogeneic CAR-T therapies are advancing toward Phase I/II clinical studies, directly addressing critical scalability bottlenecks.

Technology Developer